Skip to content
OpenCapital
Get started

Pediatrix Medical Group MD Cash & Equivalents

Cash & Equivalents at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$888.8M+1,598%
BillionToOne, Inc. logo
BillionToOne, Inc. BLLN
$537.45M+181%
ICU Medical logo
ICU MedicalICUI
$288.33M-0.5%
Universal Health Services logo
Universal Health ServicesUHS
$119.03M-6.1%
Tenet Healthcare logo
Tenet HealthcareTHC
$2.97B-1.1%
HCA Healthcare logo
HCA HealthcareHCA
$940M-11.3%

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.96B+42.9%
Enterprise value$2.38B+22.3%
P/E11.3×—
P/S1×+0.3×

Profitability

See full
Operating margin11.3%—
Net margin9%—
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%—
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's cash & equivalents?
Pediatrix Medical Group (MD) reported cash & equivalents of $205.78M in Q1 2026.
How has Pediatrix Medical Group's cash & equivalents changed year-over-year?
Pediatrix Medical Group's cash & equivalents increased by 107.9% year-over-year, from $98.98M to $205.78M.
What is the long-term trend for Pediatrix Medical Group's cash & equivalents?
Over 5 years (2020 to 2025), Pediatrix Medical Group's cash & equivalents has grown at a -19.7% compound annual growth rate (CAGR), from $1.12B to $375.24M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.